Stockreport

Amylyx gets first approval for ALS drug from Canada [Globe and Mail, The (Toronto, Canada)]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF Log in or create a free account to listen to this article. Canada has approved Amylyx Pharmaceuticals' treatment for amyotrophic lateral sclerosis (ALS), a neurodegen [Read more]